Gene replacement therapy in a schwannoma mouse model of neurofibromatosis type 2

Loss of function of the neurofibromatosis type 2 (NF2) tumor suppressor gene leads to the formation of schwannomas, meningiomas, and ependymomas, comprising ∼50% of all sporadic cases of primary nervous system tumors. NF2 syndrome is an autosomal dominant condition, with bi-allelic inactivation of g...

Descripción completa

Detalles Bibliográficos
Autores principales: Prabhakar, Shilpa, Beauchamp, Roberta L., Cheah, Pike See, Yoshinaga, Akiko, Haidar, Edwina Abou, Lule, Sevda, Mani, Gayathri, Maalouf, Katia, Stemmer-Rachamimov, Anat, Jung, David H., Welling, D. Bradley, Giovannini, Marco, Plotkin, Scott R., Maguire, Casey A., Ramesh, Vijaya, Breakefield, Xandra O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263409/
https://www.ncbi.nlm.nih.gov/pubmed/35846573
http://dx.doi.org/10.1016/j.omtm.2022.06.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263409/
https://www.ncbi.nlm.nih.gov/pubmed/35846573
http://dx.doi.org/10.1016/j.omtm.2022.06.012

Ejemplares similares